Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01727701
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CTY | CLARITHROMYCIN | A | 1J5A | 0.89 | |
ROX | ROXITHROMYCIN | A | 1JZZ | 0.83 | |
SPR | SPIRAMYCIN I | 1,2,4,A,B,C, D,E,J,K,L,M, N,O,P,R,S,T, U,V,Z | 1KD1 | 0.71 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A | 1ZT4 | 0.73 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A,C,E | 2PO6 | 0.73 | |
QPU | 1,5-anhydro-4-O-(4,6-dideoxy-4- {[(1S,2S,3S,4R,5S,6R)-2,3,4,6-tetrahydroxy- 5-methylcyclohexyl]amino}-alpha- D-glucopyranosyl)-D-glucitol | A,B,C | 2QPU | 0.71 | |
GM2 | N-[(1S,2S)-2-HYDROXY-1-({[(2R,3R,4S,5S,6R)- 3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO- 2H-PYRAN-2-YL]OXY}METHYL)OCTADECYL]OCTADECANAMIDE | A | 1GZP | 0.72 | |
DYH | (2R,3aR,6S,7R,7aR)-2-[(2S)-2-amino- 2-carboxyethyl]-6-hydroxy-7-(methylamino)hexahydro- 2H-furo[3,2-b]pyran-2-carboxylic acid | A | 2ZNT | 0.7 | |
DYH | (2R,3aR,6S,7R,7aR)-2-[(2S)-2-amino- 2-carboxyethyl]-6-hydroxy-7-(methylamino)hexahydro- 2H-furo[3,2-b]pyran-2-carboxylic acid | A,B,C,D | 3GBA | 0.7 | |
DH9 | (2S,3S,5S)-5-[(N-FORMYL-L-LEUCYL)OXY]- 2-HEXYL-3-HYDROXYHEXADECANOIC ACID | A,B | 2PX6 | 0.71 | |
A16 | 4-O-(4,6-dideoxy-4-{[(1S,2S,3S,4R,5S)- 2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}- alpha-D-glucopyranosyl)-beta-D- glucopyranose | A,B | 2VR5 | 0.71 | |
TAO | TROLEANDOMYCIN | 0 | 1OND | 0.89 | |
GSL | (2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA- D-GALACTOPYRANOSIDURONIC ACID | A | 2FIK | 0.79 | |
CAI | CARBOMYCIN A | 1,2,4,A,B,C, D,E,J,K,L,M, N,O,P,R,S,T, U,V,Z | 1K8A | 0.74 | |
PXI | 4-{[4-(DIMETHYLAMINO)-3-HYDROXY- 6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}- 12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2C6H | 0.73 | |
PXI | 4-{[4-(DIMETHYLAMINO)-3-HYDROXY- 6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}- 12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2CA0 | 0.73 | |
PXI | 4-{[4-(DIMETHYLAMINO)-3-HYDROXY- 6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}- 12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2CD8 | 0.73 | |
PXI | 4-{[4-(DIMETHYLAMINO)-3-HYDROXY- 6-METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}- 12-ETHYL-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2VZ7 | 0.73 | |
ERN | A | 2O43 | 0.89 | ||
GM3 | N-{1-[(HEXOPYRANOSYLOXY)METHYL]- 2-HYDROXYNONADECYL}TETRACOSANAMIDE | A | 2BV7 | 0.72 | |
SLT | 5-(ACETYLAMINO)-3,5-DIDEOXYNON- 2-ULOPYRANONOSYL-(2->3)-BETA-D- LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | A | 1S0I | 0.72 | |
SLT | 5-(ACETYLAMINO)-3,5-DIDEOXYNON- 2-ULOPYRANONOSYL-(2->3)-BETA-D- LYXO-HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | A | 1Z4X | 0.72 | |
NRB | NARBOMYCIN | A,B | 2VZM | 0.72 | |
NRB | NARBOMYCIN | A | 2C7X | 0.72 | |
PBS | (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA- D-GALACTOPYRANOSYL)OXY]-2-AMINO- OCTADECANE-3,4-DIOL | A,C | 1Z5L | 0.73 | |
JOS | A | 2O44 | 0.73 | ||
ERY | ERYTHROMYCIN A | A,B | 2IYF | 0.89 | |
ERY | ERYTHROMYCIN A | A,B | 3FRQ | 0.89 | |
ERY | ERYTHROMYCIN A | 0,1,2,3,9,A, B,C,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 1YI2 | 0.89 | |
ERY | ERYTHROMYCIN A | A,B | 2J0D | 0.89 | |
ERY | ERYTHROMYCIN A | A | 1JZY | 0.89 |